Bank of America reissued a buy rating and Morgan Stanley lifted the price target for Royalty Pharma.

The entities involved

• Bank of America →

  American multinational banking and financial services corporation

  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
  • Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26
• Royalty Pharma →

  biopharmaceutical company based in New York City

  • Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.Sun 17:49
  • Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sun 02:34
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Morgan Stanley, Bank of Baroda, and State Bank of India are selling shares in the NSE public offering.Mon 16:42

Related events

• Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.Sep 15
• Royalty Pharma outperformed the market so far this year, based on data from August 6, 2025.Jun 7
• Royal Bank of Canada reaffirmed rating, Citigroup began coverage, and Morgan Stanley boosted price target on Arrowhead Pharmaceuticals.Sep 11
• Major financial firms, including Raymond James, Wells Fargo, Bank of America, and Morgan Stanley, have recently adjusted price targets and issued rating updates.Aug 27
• Morgan Stanley and Royal Bank of Canada adjusted ratings and price targets for TransDigm Group Incorporated stock.Sep 19